Novilet LLC is a biotechnology startup based in Poland that focuses on developing high-tech laboratory devices utilizing the Electron Paramagnetic Resonance phenomenon. Their flagship product, a high-sensitivity spectrometer dedicated to low-frequency EPR spectroscopy, offers improved sensitivity and the ability to use lower concentrations of spin probes compared to existing systems. Additionally, the company has developed an ERI tomograph, the ERI TM 600, which is the world's only scanner enabling whole-body 3D imaging of various parameters in living organisms. Founded in 2014, Novilet's innovative technology has applications in preclinical research in areas such as oncology, neurodegeneration, and biology. With a focus on groundbreaking EPR imaging solutions, Novilet presents an exciting opportunity for investors looking to support cutting-edge biotechnology advancements.
There is no investment information
No recent news or press coverage available for Novilet LLC.